SCHEMBL3942467

SCHEMBL3942467

Nc1ccc(F)cc1.O=C(O)c1n[nH]cc1NC(=O)c1c(F)cccc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 10/20 0.48
CDK1 P06493 9/20 0.48
CCNA2 P20248 9/20 0.48
CCNB1 P14635 8/20 0.48
CCNA1 P78396 2/20 0.48
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
POLB P06746 1/20 0.40
DYRK3 O43781 1/20 0.40
PRKD3 O94806 1/20 0.40
MAP4K4 O95819 1/20 0.40
ABL1 P00519 1/20 0.40
EGFR P00533 1/20 0.40
NTRK1 P04629 1/20 0.40
PRKCG P05129 1/20 0.40
LCK P06239 1/20 0.40
FYN P06241 1/20 0.40
FES P07332 1/20 0.40
CSF1R P07333 1/20 0.40
LYN P07948 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL955039 0.90 MEN1 (0.49) CDK2CDK1CCNA2CCNB1CCNA1
SCHEMBL3939511 0.87 LMNA (0.48) MEN1KMT2AHDAC1HTTRAB9A
SCHEMBL4450271 0.86 HDAC1 (0.53) CDK2CCNA2MEN1KMT2APOLB
SCHEMBL3938477 0.82 CDK2 (0.46) CDK2CDK1CCNA2CCNB1CCNA1
SCHEMBL956928 0.82 CDK1 (0.60) CDK2CDK1CCNA2CCNB1CCNA1
SCHEMBL1645592 0.82 JAK2 (0.52) CDK2CCNA2MEN1KMT2APOLB
SCHEMBL8219373 0.81 MEN1 (0.48) CDK2CDK1CCNA2CCNB1CCNA1
SCHEMBL3937911 0.81 KMT2A (0.43) MEN1KMT2APOLBRAB9AMAPT
SCHEMBL3587804 0.80 MEN1 (0.47) CDK2CDK1CCNA2CCNB1CCNA1
SCHEMBL3936265 0.80 KMT2A (0.47) MEN1KMT2APOLBRAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049106-A2 PHARMACEUTICAL COMBINATIONS Astex Therapeutics Limited (GB) 2009-04-22 EP disclosed
EP-2046330-A2 PHARMACEUTICAL COMBINATIONS Astex Therapeutics Limited (GB) 2009-04-15 EP disclosed
WO-2008007122-A2 COMBINATIONS OF PYRAZOLE DERIVATIVES FOR THE INHIBITION OF CDKS AND GSK'S ASTEX THERAPEUTICS LIMITED (GB) 2008-01-17 WO disclosed
WO-2008007113-A2 PHARMACEUTICAL COMBINATIONS ASTEX THERAPEUTICS LIMITED (GB) 2008-01-17 WO disclosed